COMMUNIQUÉS West-GlobeNewswire

ENvue Medical Launches Over-the-Counter Reusable ENFit Syringes to Support Feeding and Medication Delivery without a Prescription
14/01/2026
New Product Line Enhances Continuity of Care Across Clinical and Home Settings TYLER, Texas, Jan. 14, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ: FEED) (NASDAQ: NAOV) (“ENvue,” “ENvue Medical” or the “Company [...]
Clover Health Announces 53% Growth in Medicare Advantage Membership During AEP, Increasing to 153,000 Members as of January 1, 2026; Expects First-Ever Full Year GAAP Net Income Profitability in 2026
14/01/2026
Clover delivers market-leading Medicare Advantage growth, establishing a strong path to achieve its first-ever full year GAAP Net Income profitability in 2026. Disciplined, core-market growth, strong returning member [...]
Beyond Air Announces $5.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules
14/01/2026
GARDEN CITY, N.Y., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of [...]
Oragenics to Present at the 2026 Sequire Investor Summit in Puerto Rico
14/01/2026
Sarasota, Fla., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN) (“the “Company”) today announced that it will be presenting at the upcoming Sequire Investor Summit 2026. The fourth edition of the [...]
Stead Impact Ventures Leads $15M Series A to Support MedWatch Technologies’ Mission to Advance Metabolic Wellness Innovation
14/01/2026
LAS VEGAS, Jan. 14, 2026 (GLOBE NEWSWIRE) -- MedWatch Technologies today announced that Stead Impact Ventures has committed to lead its $15M Series A financing, supporting the company’s mission to advance metabolic [...]
EMJX CEO Eric Jackson to Host Fireside Chat on EMJX Treasury OS Strategy and Governance on January 22nd
14/01/2026
NORTH PALM BEACH, Fla., Jan. 14, 2026 (GLOBE NEWSWIRE) -- SRx Health Solutions, Inc. (NYSE American: SRXH) (the "Company") and EMJ Crypto Technologies (“EMJX”), a digital-asset treasury operating platform with which the [...]
SCIENTURE Announces Issuance of Orange Book-Listable Patent Covering REZENOPY™, the Highest Dosage Naloxone HCl Nasal Spray Approved by the FDA for Life-Saving Opioid Overdose Emergency Treatment
14/01/2026
U.S. Naloxone Market: ~$154 million in annual sales and 9.3 million units annually COMMACK, NY, Jan. 14, 2026 (GLOBE NEWSWIRE) -- SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX), a holding company for existing and planned [...]
24/7 Market News - Kraig Labs Set to Deliver Spider Silk Fiber Samples to Three Industry Partners
14/01/2026
Deliveries will Mark Its First Commercial Sales and the Start of the Spider Silk Race DENVER, Jan. 14, 2026 (GLOBE NEWSWIRE) -- 247marketnews.com , a pioneer in digital media dedicated to the swift distribution of [...]
Groundwork BioAg Expands in Brazil with Appointment of Roberto Gajardoni as Country Manager
14/01/2026
MAZOR, Israel , Jan. 14, 2026 (GLOBE NEWSWIRE) -- Groundwork BioAg ® (“Groundwork”), the world’s largest mycorrhizal inoculant producer, announced the appointment of Roberto Gajardoni as Brazil Country Manager, marking [...]
NDT Pharmaceuticals, Inc.’s Wholly Owned Subsidiary, Good Salt Life, Inc., to Launch Dog Gone Odor® on Chewy and Amazon, Expanding its Rapidly Growing Biosafety Catalog
14/01/2026
ATHENS, Ga., Jan. 14, 2026 (GLOBE NEWSWIRE) -- NDT Pharmaceuticals, Inc. (OTC: NDTP) ($NDTP), a leader in innovative health and wellness solutions, announces that its wholly owned subsidiary, Good Salt Life, Inc ., is [...]
Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering
14/01/2026
HOUSTON, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (NASDAQ: PSTV) (the “Company”), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals for central nervous [...]
Altanine Shares Industry Perspective on the Future of Generics and the Role of Value-Added Formulations
14/01/2026
New analysis highlights how improved delivery, patient experience, and formulation science could help strengthen a strained generics market LOS ANGELES, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Altanine , a specialty [...]
RetinalGenix Reports on its Science and Mission in Light of New AI-Driven Retinal Mapping Study
14/01/2026
APOLLO BEACH, Fla., Jan. 14, 2026 (GLOBE NEWSWIRE) -- RetinalGenix Technologies Inc . [OTCQB: RTGN] (“RetinalGenix” or the “Company”), a company developing ultra-high-resolution retinal imaging technology, today [...]
Verano Strengthens National Product Portfolio in Industry’s Fastest-Growing Category with Launch of Swift Lifts as Standalone Pre-roll Brand
14/01/2026
Swift Lifts feature premium, perfectly portioned cannabis pre-rolls crafted for those who value quality and convenience CHICAGO, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“ [...]
Human Appeal Concludes First-Ever U.S. Winter Coat Drive
14/01/2026
Campaign to support families in need on the East Coast, collecting over 2,000 coats across four States FAIRFAX, Va., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Global humanitarian nonprofit Human Appeal has successfully [...]
Inside information: Orion provides outlook for 2026 and estimates that the annual Nubeqa® net sales recorded by Orion has potential to exceed EUR 1 billion in the future
14/01/2026
ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 14 JANUARY 2026 at 8:30 EET Inside information: Orion provides outlook for 2026 and estimates that the annual Nubeqa® net sales recorded by Orion has [...]
New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS
14/01/2026
14 abstracts will be presented across a range of neurological conditions including post‑stroke spasticity, cervical dystonia, blepharospasm and other movement disorders Interim data from the ongoing EPITOME trial 1 [...]
De nouvelles données renforcent l’engagement d’Ipsen à proposer des solutions et à combler les lacunes de prise en charge dans les maladies neurologiques lors du congrès TOXINS
14/01/2026
14 communications seront présentées sur un large éventail de pathologies neurologiques, notamment la spasticité post-AVC, la dystonie cervicale, le blépharospasme et d’autres troubles du mouvement Des données [...]
HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet
14/01/2026
— First randomized Phase III trial confirming the efficacy of MET inhibition in patients with advanced NSCLC and acquired MET amplification after progression on prior EGFR-TKI treatment — — Savolitinib and osimertinib [...]

Pages